A REVIEW OF AI IN CELL AND GENE THERAPY MARKET BY TECHNOLOGY, BY INDICATION, BY APPLICATION, BY END-USER (BIOPHARMACEUTICAL COMPANIES, RESEARCH INSTITUTES, HEALTHCARE PROVIDERS) AND BY REGION

The accelerated tempo of transform that gen AI promotes will require organizations to Imagine otherwise about which techniques they have to have (show 9) and exactly where to discover them—recruiting new men and women, upskilling current staff, or dynamically allocating the appropriate talent to the right priorities. ex vivo therapeutics (vehicl